Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

NCT01689558 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

1、Enough Cases
2、Elekta Precise 1343 Digital Control Electron Linear Accelerator
Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia，
Image Department of Nose Pharynx Ministry MRI Dynamic Testing,

Interventions

DRUG: Recombine Endostatin

Sponsor

Jin Feng